ProShares UltraShort Bloomberg Natrl Gas

Direxion Daily TSLA Bull 1.5X Shares

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

GraniteShares 1.5x Long NVDA Daily ETF

GraniteShares 1.25x Long Tesla Daily ETF

Direxion Daily S&P Biotech Bear 3X ETF

ProShares UltraShort Silver

Direxion Daily Gold Miners Bear 3X ETF

Direxion Daily FTSE China Bull 3X ETF

VS TR 2x Long VIX Futures ETF

ProShares Ultra Bloomberg Natural Gas

T-REX 2X Inverse Tesla Daily Target ETF

Volatility Shares Trust 2x Ether ETF

MicroSectors Gold Miners 3X Leveraged ETN

ProShares Ultra Silver

United States Natural Gas

Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily Gold Miners Bull 3X ETF

ARK Genomic Revolution Multi-Sector ETF

iShares US Home Construction

Incannex Healthcare Limited American Depositary Shares

Innovative Eyewear Inc. Common Stock

Septerna Inc. Common Stock

HWH International Inc. Common Stock

DevvStream Corp. Common Stock

Rigetti Computing Inc. Common Stock

Super Micro Computer Inc. Common Stock

Oklo Inc.

EchoStar  Corporation Common Stock

EVgo Inc. Class A Common Stock

Inno Holdings Inc. Common Stock

Gryphon Digital Mining Inc Common Stock

Next Technology Holding Inc. Ordinary Shares

Kindly MD Inc. Common Stock

Nuvve Holding Corp. Common Stock

Oriental Rise Holdings Limited Ordinary Shares

Classover Holdings Inc. Class B Common Stock

MicroAlgo Inc. Ordinary Shares

Hyperscale Data Inc. Common Stock

JELD-WEN Holding Inc. Common Stock

Click here to get full coverage on Decoding Metsera Inc (MTSR): A Strategic SWOT Insight - GuruFocus

Decoding Metsera Inc (MTSR): A Strategic SWOT Insight  GuruFocus

Decoding Metsera Inc (MTSR): A Strategic SWOT Insight - GuruFocus

Click here to get full coverage on Earnings Flash (MTSR) Metsera Posts Q1 Net Loss $1.03 a Share, vs. FactSet Est of $0.85 Loss - marketscreener.com

Earnings Flash (MTSR) Metsera Posts Q1 Net Loss $1.03 a Share, vs. FactSet Est of $0.85 Loss  marketscreener.com

Earnings Flash (MTSR) Metsera Posts Q1 Net Loss $1.03 a Share, vs. FactSet Est of $0.85 Loss - marketscreener.com

Click here to get full coverage on Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress - Yahoo Finance

Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress  Yahoo Finance

Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress - Yahoo Finance

Click here to get full coverage on Metsera: A Must-Add To Your Watchlist Thanks To GLP-1 Obesity Promise (NASDAQ:MTSR) - Seeking Alpha

Metsera: A Must-Add To Your Watchlist Thanks To GLP-1 Obesity Promise (NASDAQ:MTSR)  Seeking Alpha

Metsera: A Must-Add To Your Watchlist Thanks To GLP-1 Obesity Promise (NASDAQ:MTSR) - Seeking Alpha

Click here to get full coverage on MTSR IPO News - Obesity biotech Metsera offers fewer shares, prices IPO above the range at $18 - renaissancecapital.com

MTSR IPO News - Obesity biotech Metsera offers fewer shares, prices IPO above the range at $18  renaissancecapital.com

MTSR IPO News - Obesity biotech Metsera offers fewer shares, prices IPO above the range at $18 - renaissancecapital.com

Click here to get full coverage on Obesity Treatment Pioneer Metsera Secures Massive $316M War Chest in Oversubscribed IPO - Stock Titan

Obesity Treatment Pioneer Metsera Secures Massive $316M War Chest in Oversubscribed IPO  Stock Titan

Obesity Treatment Pioneer Metsera Secures Massive $316M War Chest in Oversubscribed IPO - Stock Titan

Click here to get full coverage on Metsera to Present at Bank of America 2025 Global Healthcare Conference - GlobeNewswire

Metsera to Present at Bank of America 2025 Global Healthcare Conference  GlobeNewswire

Metsera to Present at Bank of America 2025 Global Healthcare Conference - GlobeNewswire

Click here to get full coverage on MTSR Stock Price and Chart — NASDAQ:MTSR - TradingView

MTSR Stock Price and Chart — NASDAQ:MTSR  TradingView

MTSR Stock Price and Chart — NASDAQ:MTSR - TradingView

Click here to get full coverage on Why Did MTSR Stock Surge 15% On The Worst Trading Day Of 2025? Here's What Has Happened Since Its Listing - Benzinga

Why Did MTSR Stock Surge 15% On The Worst Trading Day Of 2025? Here's What Has Happened Since Its Listing  Benzinga

Why Did MTSR Stock Surge 15% On The Worst Trading Day Of 2025? Here's What Has Happened Since Its Listing - Benzinga

Click here to get full coverage on Metsera Moves Fast in Crowded Obesity Market With IPO Plans - BioSpace

Metsera Moves Fast in Crowded Obesity Market With IPO Plans  BioSpace

Metsera Moves Fast in Crowded Obesity Market With IPO Plans - BioSpace

Click here to get full coverage on Is Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Is Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently?  Insider Monkey

Is Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Click here to get full coverage on Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently - Yahoo Finance

Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently  Yahoo Finance

Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently - Yahoo Finance

Click here to get full coverage on MTSR IPO News - Obesity biotech Metsera sets terms for $275 million IPO - renaissancecapital.com

MTSR IPO News - Obesity biotech Metsera sets terms for $275 million IPO  renaissancecapital.com

MTSR IPO News - Obesity biotech Metsera sets terms for $275 million IPO - renaissancecapital.com

Click here to get full coverage on Metsera Readies $275 Million IPO For Obesity Treatments (Pending:MTSR) - Seeking Alpha

Metsera Readies $275 Million IPO For Obesity Treatments (Pending:MTSR)  Seeking Alpha

Metsera Readies $275 Million IPO For Obesity Treatments (Pending:MTSR) - Seeking Alpha

Click here to get full coverage on Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress - GlobeNewswire

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress  GlobeNewswire

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress - GlobeNewswire

Click here to get full coverage on Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month - Yahoo Home

Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month  Yahoo Home

Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month - Yahoo Home

Click here to get full coverage on Metsera: Capturing Of Obesity Market With Long-Acting GLP-1 Differentiation - Seeking Alpha

Metsera: Capturing Of Obesity Market With Long-Acting GLP-1 Differentiation  Seeking Alpha

Metsera: Capturing Of Obesity Market With Long-Acting GLP-1 Differentiation - Seeking Alpha

Click here to get full coverage on Metsera: MTSR IPO, Health Care - Phase 2 biotech developing nutrient stimulated hormone analog peptides for obesity. - renaissancecapital.com

Metsera: MTSR IPO, Health Care - Phase 2 biotech developing nutrient stimulated hormone analog peptides for obesity.  renaissancecapital.com

Metsera: MTSR IPO, Health Care - Phase 2 biotech developing nutrient stimulated hormone analog peptides for obesity. - renaissancecapital.com

Click here to get full coverage on Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s - MedCity News

Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s  MedCity News

Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s - MedCity News

Click here to get full coverage on MTSR IPO News - Obesity biotech Metsera files for a $100 million IPO - renaissancecapital.com

MTSR IPO News - Obesity biotech Metsera files for a $100 million IPO  renaissancecapital.com

MTSR IPO News - Obesity biotech Metsera files for a $100 million IPO - renaissancecapital.com

Click here to get full coverage on Metsera, Maze secure combined $415 million in IPOs - BioPharma Dive

Metsera, Maze secure combined $415 million in IPOs  BioPharma Dive

Metsera, Maze secure combined $415 million in IPOs - BioPharma Dive

Click here to get full coverage on Lilly stock up rallying Structure and Metsera (GPCR:NASDAQ) - Seeking Alpha

Lilly stock up rallying Structure and Metsera (GPCR:NASDAQ)  Seeking Alpha

Lilly stock up rallying Structure and Metsera (GPCR:NASDAQ) - Seeking Alpha

Click here to get full coverage on Obesity-focused Metsera files IPO just 9 months after emerging - Fierce Biotech

Obesity-focused Metsera files IPO just 9 months after emerging  Fierce Biotech

Obesity-focused Metsera files IPO just 9 months after emerging - Fierce Biotech

Click here to get full coverage on Metsera Prices Initial Public Offering at $18 Per Share - The Healthcare Technology Report.

Metsera Prices Initial Public Offering at $18 Per Share  The Healthcare Technology Report.

Metsera Prices Initial Public Offering at $18 Per Share - The Healthcare Technology Report.

Click here to get full coverage on Weight-loss drug developer Metsera reveals wider loss in US IPO filing - Reuters

Weight-loss drug developer Metsera reveals wider loss in US IPO filing  Reuters

Weight-loss drug developer Metsera reveals wider loss in US IPO filing - Reuters

Click here to get full coverage on Metsera, Inc. awards full bonuses to executive officers - Investing.com

Metsera, Inc. awards full bonuses to executive officers  Investing.com

Metsera, Inc. awards full bonuses to executive officers - Investing.com

Click here to get full coverage on Cantor Fitzgerald initiates Metsera with overweight rating - Investing.com

Cantor Fitzgerald initiates Metsera with overweight rating  Investing.com

Cantor Fitzgerald initiates Metsera with overweight rating - Investing.com

Click here to get full coverage on BofA sets Metsera stock Buy rating, $38 price target - Investing.com

BofA sets Metsera stock Buy rating, $38 price target  Investing.com

BofA sets Metsera stock Buy rating, $38 price target - Investing.com

Click here to get full coverage on Obesity drug developer Metsera sets terms for $275M IPO - Seeking Alpha

Obesity drug developer Metsera sets terms for $275M IPO  Seeking Alpha

Obesity drug developer Metsera sets terms for $275M IPO - Seeking Alpha

Click here to get full coverage on Busy day for biotech IPOs as Metsera, Maze go public with offerings totaling nearly $400M - Fierce Biotech

Busy day for biotech IPOs as Metsera, Maze go public with offerings totaling nearly $400M  Fierce Biotech

Busy day for biotech IPOs as Metsera, Maze go public with offerings totaling nearly $400M - Fierce Biotech

Click here to get full coverage on Guggenheim sets Metsera stock Buy rating, $56 target - Investing.com

Guggenheim sets Metsera stock Buy rating, $56 target  Investing.com

Guggenheim sets Metsera stock Buy rating, $56 target - Investing.com

Click here to get full coverage on MicroStrategy (MSTR) Opens With 13% Surge - U.Today

MicroStrategy (MSTR) Opens With 13% Surge  U.Today

MicroStrategy (MSTR) Opens With 13% Surge - U.Today

Click here to get full coverage on 12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session  Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Click here to get full coverage on 18th International Conference on Metadata and Semantics Research (MTSR 2024) - Hub ΕΚΠΑ

18th International Conference on Metadata and Semantics Research (MTSR 2024)  Hub ΕΚΠΑ

18th International Conference on Metadata and Semantics Research (MTSR 2024) - Hub ΕΚΠΑ

Click here to get full coverage on Metsera Inc. appoints new director and legal officer By Investing.com - Investing.com Nigeria

Metsera Inc. appoints new director and legal officer By Investing.com  Investing.com Nigeria

Metsera Inc. appoints new director and legal officer By Investing.com - Investing.com Nigeria

Click here to get full coverage on Process flow of the expanded Stoessel criticality diagram. MTSR,... - ResearchGate

Process flow of the expanded Stoessel criticality diagram. MTSR,...  ResearchGate

Process flow of the expanded Stoessel criticality diagram. MTSR,... - ResearchGate

Click here to get full coverage on Google Ventures-Backed Biotech Metsera Seeks $292 Million in IPO - BNN Bloomberg

Google Ventures-Backed Biotech Metsera Seeks $292 Million in IPO  BNN Bloomberg

Google Ventures-Backed Biotech Metsera Seeks $292 Million in IPO - BNN Bloomberg

Click here to get full coverage on Science Applications Posts Better-Than-Expected Earnings, Joins Qifu Technology, Baidu, American Eagle And Other Big Stocks Moving Higher On Monday - Alpha Technology Group (NASDAQ:ATGL), American Eagle Outfitters (NYSE:AEO) - Benzinga

Science Applications Posts Better-Than-Expected Earnings, Joins Qifu Technology, Baidu, American Eagle And Other Big Stocks Moving Higher On Monday - Alpha Technology Group (NASDAQ:ATGL), American Eagle Outfitters (NYSE:AEO)  Benzinga

Science Applications Posts Better-Than-Expected Earnings, Joins Qifu Technology, Baidu, American Eagle And Other Big Stocks Moving Higher On Monday - Alpha Technology Group (NASDAQ:ATGL), American Eagle Outfitters (NYSE:AEO) - Benzinga

Click here to get full coverage on KB Home Posts Downbeat Results, Joins UniFirst, Oklo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

KB Home Posts Downbeat Results, Joins UniFirst, Oklo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session  Benzinga

KB Home Posts Downbeat Results, Joins UniFirst, Oklo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Click here to get full coverage on The energy-dispersive X-ray analysis with a single point EDX mapping... - ResearchGate

The energy-dispersive X-ray analysis with a single point EDX mapping...  ResearchGate

The energy-dispersive X-ray analysis with a single point EDX mapping... - ResearchGate

Click here to get full coverage on News - New robots help EOD teams do jobs safer, better, faster - DVIDS

News - New robots help EOD teams do jobs safer, better, faster  DVIDS

News - New robots help EOD teams do jobs safer, better, faster - DVIDS

Click here to get full coverage on Transcriptomic Analysis of Streptococcus pyogenes Colonizing the Vaginal Mucosa Identifies hupY , an MtsR-Regulated Adhesin Involved in Heme Utilization - ASM Journals

Transcriptomic Analysis of Streptococcus pyogenes Colonizing the Vaginal Mucosa Identifies hupY , an MtsR-Regulated Adhesin Involved in Heme Utilization  ASM Journals

Transcriptomic Analysis of Streptococcus pyogenes Colonizing the Vaginal Mucosa Identifies hupY , an MtsR-Regulated Adhesin Involved in Heme Utilization - ASM Journals

Click here to get full coverage on FIG 2 Differential regulation of MtsR-regulated operons in GAS and GBS... - ResearchGate

FIG 2 Differential regulation of MtsR-regulated operons in GAS and GBS...  ResearchGate

FIG 2 Differential regulation of MtsR-regulated operons in GAS and GBS... - ResearchGate

Click here to get full coverage on M'sian livestock industry's total trade up 23.2% to RM1.4b in 2023 — official data - The Edge Malaysia

M'sian livestock industry's total trade up 23.2% to RM1.4b in 2023 — official data  The Edge Malaysia

M'sian livestock industry's total trade up 23.2% to RM1.4b in 2023 — official data - The Edge Malaysia

Click here to get full coverage on Figure 3. Synthesis reaction of melamine and formaldehyde resulting in... - ResearchGate

Figure 3. Synthesis reaction of melamine and formaldehyde resulting in...  ResearchGate

Figure 3. Synthesis reaction of melamine and formaldehyde resulting in... - ResearchGate

Click here to get full coverage on Figure 7. TG/DTG thermal analysis curves of the materials. Melamine in... - ResearchGate

Figure 7. TG/DTG thermal analysis curves of the materials. Melamine in...  ResearchGate

Figure 7. TG/DTG thermal analysis curves of the materials. Melamine in... - ResearchGate

Click here to get full coverage on Malaysia's livestock trade jumps 23.2pct to RM1.4bil in 2023: DOSM - NST Online

Malaysia's livestock trade jumps 23.2pct to RM1.4bil in 2023: DOSM  NST Online

Malaysia's livestock trade jumps 23.2pct to RM1.4bil in 2023: DOSM - NST Online

Click here to get full coverage on Malaysia’s livestock industry total trade increases RM254.7 million to RM1.4 billion in 2023 - DOSM - thesun.my

Malaysia’s livestock industry total trade increases RM254.7 million to RM1.4 billion in 2023 - DOSM  thesun.my

Malaysia’s livestock industry total trade increases RM254.7 million to RM1.4 billion in 2023 - DOSM - thesun.my

Click here to get full coverage on Malaysia exports RM52.3 billion of palm oil in 2020, or 73pct of agriculture exports - NST Online

Malaysia exports RM52.3 billion of palm oil in 2020, or 73pct of agriculture exports  NST Online

Malaysia exports RM52.3 billion of palm oil in 2020, or 73pct of agriculture exports - NST Online

Click here to get full coverage on Metsera (NASDAQ:MTSR) Shares Gap Up – Time to Buy? - Defense World

Metsera (NASDAQ:MTSR) Shares Gap Up – Time to Buy?  Defense World

MTSR

Price Chart

Key Statistics

Technicals

About MTSR

Latest News

Decoding Metsera Inc (MTSR): A Strategic SWOT Insight - GuruFocus

Earnings Flash (MTSR) Metsera Posts Q1 Net Loss $1.03 a Share, vs. FactSet Est of $0.85 Loss - marketscreener.com

Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers